Literature DB >> 9714503

Antiepileptic effects of topiramate on amygdaloid kindling in rats.

K Amano1, K Hamada, K Yagi, M Seino.   

Abstract

We examined the antiepileptic properties of topiramate (TPM) in amygdaloid (AM) kindling in rats. Electrodes were implanted into the left AM of adult male Wistar rats. The animals were kindled at the after-discharge (AD) threshold. After the completion of kindling, the generalized seizure triggering threshold was determined. The drugs were administered intraperitoneally in animals which showed stable generalized convulsions at near-threshold stimulation. Intraperitoneal administration of TPM at doses of 25 mg/kg or more produced an anticonvulsive effect, but did not readily suppress limbic seizures. Complete suppression of AD was observed in only 3/8 rats at the highest dose of 200 mg/kg, which was not statistically significant. On the other hand, TPM at 100 and 200 mg/kg significantly delayed AM kindling. Thus, TPM showed modest therapeutic properties of conventional antiepileptic drugs in kindling model, those of TPM more closely resemble those of phenobarbital and the benzodiazepines than those of phenytoin and carbamazepine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714503     DOI: 10.1016/s0920-1211(98)00021-7

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

1.  Limbic epileptogenesis: a model study using kindling from the amygloid cortical nucleus.

Authors:  A F Bikbaev; A V Karpova; S A Chepurnov; N E Chepurnova; L B Kalimullina
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

Review 2.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Antiepileptic drugs for the treatment of post-traumatic stress disorder.

Authors:  Heather A Berlin
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

4.  Antiepileptogenic agents: how close are we?

Authors:  N R Temkin; A D Jarell; G D Anderson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.

Authors:  Rafal M Kaminski; Michael A Rogawski; Henrik Klitgaard
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

6.  Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling.

Authors:  Raman Sankar; Stéphane Auvin; Young Se Kwon; Eduardo Pineda; Don Shin; Andréy Mazarati
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

Review 7.  Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.

Authors:  Bryan L Clossen; Doodipala Samba Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-05       Impact factor: 5.187

8.  Age-dependent effects of topiramate on the acquisition and the retention of rapid kindling.

Authors:  Andréy Mazarati; Don Shin; Stéphane Auvin; Raman Sankar
Journal:  Epilepsia       Date:  2007-02-23       Impact factor: 5.864

Review 9.  Topiramate: as monotherapy in newly diagnosed epilepsy.

Authors:  John Waugh; Karen L Goa
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.

Authors:  Jeffrey L Berlant
Journal:  BMC Psychiatry       Date:  2004-08-18       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.